[1]
|
Collins AE, Ferriero DM. “The expanding spectrum of congenital disorders of glycosylation”, J Pediatr, Vol 147, 2005, pp 728-30.
|
[2]
|
Leonard J, Grunewald S, Clayton P. “Diversity of congenital disorders of glycosylation”, Lancet, Vol 357, 2001 pp 1382-3.
|
[3]
|
Engelhardt H, Staudt M, Hassler A et al. “Carbohydrate-deficient glycoprotein syndrome type 2”, J Inherit Metab Dis, Vol 22, 1999, pp 192-3.
|
[4]
|
Marquardt T, Denecke J. “Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies”, Eur J Pediatr, Vol 162, 2003, pp 359-79.
|
[5]
|
Kusa J, Pyrkosz A, Skiba A, Szkutnik M. “Cardiac manifestations of carbohydrate-deficient glycoprotein syndrome”, Pediatr Cardiol, Vol 24, 2003, pp 493-4.
|
[6]
|
Meaudre E, Meyrieux V, Suprano I et al. “Anesthesia considerations in carbohydrate-deficient glycoprotein syndrome type I”, Paediatr Anaesth Vol 15, 2005, pp 905-6.
|
[7]
|
Rama-Maceiras P, Ferreira TA, Molins N et al. “Less postoperative nausea and vomiting after propofol + remifentanil versus propofol + fentanyl anaesthesia during plastic surgery”, Acta Anaesthesiol Scand, Vol 49, 2005, pp 305-11.
|
[8]
|
Loop T, Priebe HJ. “Recovery after anesthesia with remifentanil combined with propofol, desflurane, or sevoflurane for otorhinolaryngeal surgery”, Anesth Analg, Vol 91, 2000, pp 123-9.
|
[9]
|
Thompson JP, Rowbotham DJ. “Remifentanil--an opioid for the 21st century”, Br J Anaesth Vol 76, 1996, pp 341-3.
|